BioNTech SE Net Common Equity Issued/Repurchased 2019-2025 | BNTX

BioNTech SE net common equity issued/repurchased for the twelve months ending March 31, 2025 was $0M, a 100% decline year-over-year.

  • BioNTech SE annual net common equity issued/repurchased for 2024 was $0B, a 100% decline from 2023.
  • BioNTech SE annual net common equity issued/repurchased for 2023 was $-0.799B, a 13.39% decline from 2022.
  • BioNTech SE annual net common equity issued/repurchased for 2022 was $-0.923B, a 584.79% decline from 2021.

BioNTech SE Net Common Equity Issued/Repurchased 2019-2025 | BNTX

  • BioNTech SE annual net common equity issued/repurchased for 2024 was $0B, a 100% decline from 2023.
  • BioNTech SE annual net common equity issued/repurchased for 2023 was $-0.799B, a 13.39% decline from 2022.
  • BioNTech SE annual net common equity issued/repurchased for 2022 was $-0.923B, a 584.79% decline from 2021.